fbpx
A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Study Identifies Potential New Combination Therapy to Treat Head and Neck Cancer

Researchers at the UCLA Jonsson Comprehensive Cancer Center and UCLA School of Dentistry may have found a new combination therapy to treat advanced head and neck squamous cell carcinoma, according to a recent study. 

0

Researchers at the UCLA Jonsson Comprehensive Cancer Center and UCLA School of Dentistry may have found a new combination therapy to treat advanced head and neck squamous cell carcinoma, according to a recent study. 

Using a mouse model of head and neck squamous cell carcinoma, researchers  found “that using an anti-PD1 immunotherapy drug in combination with PTC209, an inhibitor that targets the protein BMI1, successfully stopped the growth and spread of cancer, prevented reoccurrences and eliminated cancer stem cells.”

The study, “BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse,” was published in Cell Stem Cell

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy